Background: In December 2019, cases of pneumonia (COVID-19) due to a new coronavirus infection (SARS-COV-2) started to appear in Wuhan City, China. It quickly spread from China to the whole world. In our study, we objective to investigate the demographic data, applied treatments and outcomes of the patients with COVID-19 that we followed in our clinic according to their genders. Methods: In this study, we included a total of 96 patients whose clinical, radiological or laboratory parameters were compatible with COVID-19 and who were hospitalised, treated and followed-up in our Internal Medicine Clinic. The demographic data, treatments and prognostic data of these patients were retrospectively recorded and analysed in order to see if there were statistically significant differences between genders. Results: The average age of all COVID-19 cases included in our study was 63.54 ± 15.8. The average age of male patients was 65.6 ± 14.44 and the one of female patients was 61.82 ± 17.1: no statistical significance was found. The number of smoking male patients was 16, and this value was found to be 3 in females, and it was statistically significantly higher in males (p <0.05). Conclusion: No significant recommandations was found between male and female patients based on their demographic data, symptoms, treatments and outcomes.